APP-based Multifaceted Management After PCI
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03059784|
Recruitment Status : Unknown
Verified February 2017 by Yongjian Wu, Chinese Academy of Medical Sciences, Fuwai Hospital.
Recruitment status was: Not yet recruiting
First Posted : February 23, 2017
Last Update Posted : February 23, 2017
|Condition or disease||Intervention/treatment||Phase|
|Percutaneous Coronary Intervention||Other: APP-based multifaceted management||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||1100 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||Mobile Application-based Multifaceted Management to Improve Long-term Care After Percutaneous Coronary Intervention|
|Estimated Study Start Date :||March 2017|
|Estimated Primary Completion Date :||July 2018|
|Estimated Study Completion Date :||August 2018|
APP-based multifaceted management, including sending education material, everyday medication reminder, giving risk factor control support, clinical support to patients after PCI through APP.
Other: APP-based multifaceted management
Patients after PCI will be regularly given education materials, medication reminders, life-style behaviors instruction through APP. Cardiologists can interact with patients on advice provision and clinical support after discharge through APP.
No Intervention: control
usual care without APP
- evidence-based medication adherence (the proportion of participants taking 3 medications (aspirin, P2Y12 receptor inhibitor, statin) without contraindications) [ Time Frame: at 12 months after PCI ]the proportion of participants taking 3 medications (aspirin, P2Y12 receptor inhibitor, statin) without contraindications
- rate of LDL-C achieving target [ Time Frame: at 12 months after PCI ]rate of LDL-C achieving target based on guideline
- rate of systolic blood pressure achieving target [ Time Frame: at 12 months after PCI ]rate of systolic blood pressure achieving target based on guideline
- readmission rate [ Time Frame: 12 months after PCI ]readmission rate after PCI
- smoking status (the proportion of participants with smoking cessation) [ Time Frame: at 12 months after PCI ]the proportion of participants with smoking cessation
- rehabilitation (the proportion of participants who receive rehabilitation program) [ Time Frame: 12 months after PCI ]the proportion of participants who receive rehabilitation program
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03059784
|Contact: HAIYAN XUemail@example.com|
|Study Chair:||Yongjian Wu||Fuwai Hospital|